Spinal SIRT1 activation attenuates neuropathic pain in mice

PLoS ONE

Volumn 9, Issue 6, 2014, Pages

  Shao, Haijun ^a   Xue, Qingsheng ^a   Zhang, Fujun ^a   Luo, Yan ^a   Zhu, Hao ^b   Zhang, Xiaoqing ^a   Zhang, Honghai ^c   Ding, Wenlong ^b   Yu, Buwei ^a  

^a SHANGHAI SECOND MEDICAL UNIVERSITY   (China)

^b SHANGHAI JIAO TONG UNIVERSITY SCHOOL OF MEDICINE   (China)

^c NANJING MEDICAL UNIVERSITY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

NICOTINAMIDE; NICOTINAMIDE ADENINE DINUCLEOTIDE; RESVERATROL; SELISISTAT; SIRTUIN 1; SIRT1 PROTEIN, MOUSE; STILBENE DERIVATIVE;

ADULT; ALLODYNIA; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTINOCICEPTION; ARTICLE; ATTENUATION; CONTROLLED STUDY; DOSE RESPONSE; DOWN REGULATION; DRUG DOSE COMPARISON; DRUG EFFECT; DRUG MECHANISM; ENZYME ACTIVATION; ENZYME ACTIVITY; ENZYME ANALYSIS; EXPERIMENTAL BEHAVIORAL TEST; HYPERALGESIA; IMMUNOBLOTTING; MALE; MASS SPECTROMETRY; MOUSE; NEUROPATHIC PAIN; NOCICEPTION; NONHUMAN; PROTEIN CONTENT; PROTEIN EXPRESSION; SIGNAL TRANSDUCTION; SPINAL CORD; TISSUE LEVEL; ANIMAL; GENETICS; INBRED MOUSE STRAIN; METABOLISM; NEURALGIA; PHYSIOLOGY;

ANIMALS; DOWN-REGULATION; HYPERALGESIA; MALE; MICE; MICE, INBRED STRAINS; NAD; NEURALGIA; NIACINAMIDE; SIRTUIN 1; SPINAL CORD; STILBENES;

EID: 84903531034     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0100938     Document Type: Article

References (47)

1. Baron R (2006) Mechanisms of disease: neuropathic pain - a clinical perspective. Nat Clin Pract Neurol 2: 95-106.
2. Uchida H, Ma L, Ueda H (2010) Epigenetic gene silencing underlies C-fiber dysfunctions in neuropathic pain. J Neurosci 30: 4806-4814.
3. Uchida H, Sasaki K, Ma L, Ueda H (2010) Neuron-restrictive silencer factor causes epigenetic silencing of Kv4.3 gene after peripheral nerve injury. Neuroscience 166: 1-4.
4. Adilakshmi T, Sudol I, Tapinos N (2012) Combinatorial action of miRNAs regulates transcriptional and post-transcriptional gene silencing following in vivo PNS injury. PLoS One 7: e39674.
5. Wang Y, Nowicki MO, Wang X, Arnold WD, Fernandez SA, et al. (2012) Comparative effectiveness of antinociceptive gene therapies in animal models of diabetic neuropathic pain. Gene Ther.
6. Uchida H, Matsushita Y, Ueda H (2013) Epigenetic regulation of BDNF expression in the primary sensory neurons after peripheral nerve injury: implications in the development of neuropathic pain. Neuroscience 240: 147-154.
7. Kiguchi N, Kobayashi Y, Maeda T, Fukazawa Y, Tohya K, et al. (2012) Epigenetic augmentation of the macrophage inflammatory protein 2/C-X-C chemokine receptor type 2 axis through histone H3 acetylation in injured peripheral nerves elicits neuropathic pain. J Pharmacol Exp Ther 340: 577-587.
8. Chiechio S, Zammataro M, Morales ME, Busceti CL, Drago F, et al. (2009) Epigenetic modulation of mGlu2 receptors by histone deacetylase inhibitors in the treatment of inflammatory pain. Mol Pharmacol 75: 1014-1020.
9. Denk F, Huang W, Sidders B, Bithell A, Crow M, et al. (2013) HDAC inhibitors attenuate the development of hypersensitivity in models of neuropathic pain. Pain 154: 1668-1679.
10. Tissenbaum HA, Guarente L (2001) Increased dosage of a sir-2 gene extends lifespan in Caenorhabditis elegans. Nature 410: 227-230. (Pubitemid 32216597)
11. Finkel T, Deng CX, Mostoslavsky R (2009) Recent progress in the biology and physiology of sirtuins. Nature 460: 587-591.
12. Nakahata Y, Kaluzova M, Grimaldi B, Sahar S, Hirayama J, et al. (2008) The NAD+-dependent deacetylase SIRT1 modulates CLOCK-mediated chromatin remodeling and circadian control. Cell 134: 329-340. (Pubitemid 352010336)
13. Nakahata Y, Sahar S, Astarita G, Kaluzova M, Sassone-Corsi P (2009) Circadian control of the NAD+ salvage pathway by CLOCK-SIRT1. Science 324: 654-657.
14. Kim D, Nguyen MD, Dobbin MM, Fischer A, Sananbenesi F, et al. (2007) SIRT1 deacetylase protects against neurodegeneration in models for Alzheimer's disease and amyotrophic lateral sclerosis. EMBO J 26: 3169-3179. (Pubitemid 47057498)
15. Bellamacina CR (1996) The nicotinamide dinucleotide binding motif: a comparison of nucleotide binding proteins. FASEB J 10: 1257-1269.
16. Blander G, Guarente L (2004) The Sir2 family of protein deacetylases. Annu Rev Biochem 73: 417-435. (Pubitemid 39050375)
17. Bitterman KJ, Anderson RM, Cohen HY, Latorre-Esteves M, Sinclair DA (2002) Inhibition of silencing and accelerated aging by nicotinamide, a putative negative regulator of yeast sir2 and human SIRT1. J Biol Chem 277: 45099-45107. (Pubitemid 36159111)
18. Araki T, Sasaki Y, Milbrandt J (2004) Increased nuclear NAD biosynthesis and SIRT1 activation prevent axonal degeneration. Science 305: 1010-1013. (Pubitemid 39071777)
19. Milne JC, Denu JM (2008) The Sirtuin family: therapeutic targets to treat diseases of aging. Curr Opin Chem Biol 12: 11-17.
20. Wuertz K, Quero L, Sekiguchi M, Klawitter M, Nerlich A, et al. (2011) The red wine polyphenol resveratrol shows promising potential for the treatment of nucleus pulposus-mediated pain in vitro and in vivo. Spine (Phila Pa 1976) 36: E1373-1384.
21. Yin Q, Lu FF, Zhao Y, Cheng MY, Fan Q, et al. (2013) Resveratrol Facilitates Pain Attenuation in a Rat Model of Neuropathic Pain Through the Activation of Spinal Sirt1. Reg Anesth Pain Med.
22. Tillu DV, Melemedjian OK, Asiedu MN, Qu N, De Felice M, et al. (2012) Resveratrol engages AMPK to attenuate ERK and mTOR signaling in sensory neurons and inhibits incision-induced acute and chronic pain. Mol Pain 8: 5.
23. Tsai RY, Chou KY, Shen CH, Chien CC, Tsai WY, et al. (2012) Resveratrol regulates N-methyl-D-aspartate receptor expression and suppresses neuroinflammation in morphine-tolerant rats. Anesth Analg 115: 944-952.
24. Napper AD, Hixon J, McDonagh T, Keavey K, Pons JF, et al. (2005) Discovery of indoles as potent and selective inhibitors of the deacetylase SIRT1. J Med Chem 48: 8045-8054. (Pubitemid 41798434)
25. Peck B, Chen CY, Ho KK, Di Fruscia P, Myatt SS, et al. (2010) SIRT inhibitors induce cell death and p53 acetylation through targeting both SIRT1 and SIRT2. Mol Cancer Ther 9: 844-855.
26. Lee JC, Shin JH, Park BW, Kim GS, Kim JC, et al. (2012) Region-specific changes in the immunoreactivity of SIRT1 expression in the central nervous system of SOD1(G93A) transgenic mice as an in vivo model of amyotrophic lateral sclerosis. Brain Res 1433: 20-28.
27. Hylden JL, Wilcox GL (1980) Intrathecal morphine in mice: a new technique. Eur J Pharmacol 67: 313-316. (Pubitemid 10007057)
28. Klaidman LK, Mukherjee SK, Hutchin TP, Adams JD (1996) Nicotinamide as a precursor for NAD+ prevents apoptosis in the mouse brain induced by tertiary-butylhydroperoxide. Neurosci Lett 206: 5-8. (Pubitemid 26086272)
29. Hoane MR, Pierce JL, Holland MA, Anderson GD (2008) Nicotinamide treatment induces behavioral recovery when administered up to 4 hours following cortical contusion injury in the rat. Neuroscience 154: 861-868.
30. Perez-Severiano F, Bermudez-Ocana DY, Lopez-Sanchez P, Rios C, Granados-Soto V (2008) Spinal nerve ligation reduces nitric oxide synthase activity and expression: effect of resveratrol. Pharmacol Biochem Behav 90: 742-747.
31. Bermudez-Ocana DY, Ambriz-Tututi M, Perez-Severiano F, Granados-Soto V (2006) Pharmacological evidence for the participation of NO-cyclic GMP-PKG-K+ channel pathway in the antiallodynic action of resveratrol. Pharmacol Biochem Behav 84: 535-542. (Pubitemid 44292253)
32. Bennett GJ, Xie YK (1988) A peripheral mononeuropathy in rat that produces disorders of pain sensation like those seen in man. Pain 33: 87-107.
33. Hargreaves K, Dubner R, Brown F, Flores C, Joris J (1988) A new and sensitive method for measuring thermal nociception in cutaneous hyperalgesia. Pain 32: 77-88.
34. Bradford MM (1976) A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Anal Biochem 72: 248-254.
35. Vaquero A, Scher M, Lee D, Erdjument-Bromage H, Tempst P, et al. (2004) Human SirT1 interacts with histone H1 and promotes formation of facultative heterochromatin. Mol Cell 16: 93-105. (Pubitemid 39330155)
36. Bruzzone S, Guida L, Zocchi E, Franco L, De Flora A (2001) Connexin 43 hemi channels mediate Ca2+-regulated transmembrane NAD+ fluxes in intact cells. FASEB J 15: 10-12.
37. Wood JG, Rogina B, Lavu S, Howitz K, Helfand SL, et al. (2004) Sirtuin activators mimic caloric restriction and delay ageing in metazoans. Nature 430: 686-689. (Pubitemid 39061685)
38. Baur JA, Sinclair DA (2006) Therapeutic potential of resveratrol: the in vivo evidence. Nat Rev Drug Discov 5: 493-506. (Pubitemid 44136961)
39. Zakhary SM, Ayubcha D, Dileo JN, Jose R, Leheste JR, et al. (2010) Distribution analysis of deacetylase SIRT1 in rodent and human nervous systems. Anat Rec (Hoboken) 293: 1024-1032.
40. Renthal W, Kumar A, Xiao G, Wilkinson M, Covington HE 3rd, et al. (2009) Genome-wide analysis of chromatin regulation by cocaine reveals a role for sirtuins. Neuron 62: 335-348.
41. Imai S, Saeki M, Yanase M, Horiuchi H, Abe M, et al. (2011) Change in microRNAs associated with neuronal adaptive responses in the nucleus accumbens under neuropathic pain. J Neurosci 31: 15294-15299.
42. Borrelli E, Nestler EJ, Allis CD, Sassone-Corsi P (2008) Decoding the epigenetic language of neuronal plasticity. Neuron 60: 961-974.
43. Imai S (2009) From heterochromatin islands to the NAD World: a hierarchical view of aging through the functions of mammalian Sirt1 and systemic NAD biosynthesis. Biochim Biophys Acta 1790: 997-1004.
44. Qin W, Yang T, Ho L, Zhao Z, Wang J, et al. (2006) Neuronal SIRT1 activation as a novel mechanism underlying the prevention of Alzheimer disease amyloid neuropathology by calorie restriction. J Biol Chem 281: 21745-21754. (Pubitemid 44181878)
45. Larrosa M, Azorin-Ortuno M, Yanez-Gascon MJ, Garcia-Conesa MT, Tomas-Barberan F, et al. (2011) Lack of effect of oral administration of resveratrol in LPS-induced systemic inflammation. Eur J Nutr 50: 673-680.
46. Pacholec M, Bleasdale JE, Chrunyk B, Cunningham D, Flynn D, et al. (2010) SRT1720, SRT2183, SRT1460, and resveratrol are not direct activators of SIRT1. J Biol Chem 285: 8340-8351.
47. Tang BL (2010) Resveratrol is neuroprotective because it is not a direct activator of Sirt1-A hypothesis. Brain Res Bull 81: 359-361.